MyLymphomaTeam

For diffuse large B-cell lymphoma (DLBCL), approximately 30-40% of patients will experience a relapse within two years of completing their initial treatment, even after achieving complete remission.

The risk of relapse decreases the longer a patient stays in remission. Here are the relapse rates after achieving 2 years of Show Full Answer

For diffuse large B-cell lymphoma (DLBCL), approximately 30-40% of patients will experience a relapse within two years of completing their initial treatment, even after achieving complete remission.

The risk of relapse decreases the longer a patient stays in remission. Here are the relapse rates after achieving 2 years of complete response:
• 6.9% relapse after 3 years
• 9.3% relapse after 5 years
• 10.3% relapse after 8 years If DLBCL does relapse and second-line treatment is needed, about 44% of patients can achieve a second remission. However, the chances of reaching remission typically decrease with each subsequent relapse. Early detection of relapse symptoms is important, as it can lead to better outcomes when treated promptly.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

DLBCL Relapse: 4 Symptoms To Watch For

DLBCL Relapse Rate and Treatment Options